Personalized Medicine in Breast Cancer: A Systematic Review / 한국유방암학회지
Journal of Breast Cancer
;
: 265-272, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-200196
ABSTRACT
The recent advent of "-omics" technologies have heralded a new era of personalized medicine. Personalized medicine is referred to as the ability to segment heterogeneous subsets of patients whose response to a therapeutic intervention within each subset is homogeneous. This new paradigm in healthcare is beginning to affect both research and clinical practice. The key to success in personalized medicine is to uncover molecular biomarkers that drive individual variability in clinical outcomes or drug responses. In this review, we begin with an overview of personalized medicine in breast cancer and illustrate the most encountered statistical approaches in the recent literature tailored for uncovering gene signatures.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Mama
/
Neoplasias de la Mama
/
Biomarcadores
/
Atención a la Salud
/
Medicina de Precisión
Tipo de estudio:
Estudio pronóstico
/
Revisiones Sistemáticas Evaluadas
Límite:
Humanos
Idioma:
Inglés
Revista:
Journal of Breast Cancer
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS